June 8, 2012 — Children and young adults scanned multiple times by computed tomography (CT) have a small increased risk of leukemia and brain tumors in the decade following their first scan. These findings are from a study of more than 175,000 children and young adults that was led by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, and at the Institute of Health and Society, Newcastle University, England.

June 8, 2012 — Bayer Radiology and Interventional has announced the introduction of the Certegra Workstation, an informatics-driven, touch-screen hub that enables time savings and improved patient care through a suite of CT (computed tomography) Contrast Dose Management applications and a new P3T 2.0 operating environment.

June 8, 2012 — The U.S. Food and Drug Administration (FDA) has approved revised product labeling for Boston Scientific Corp.’s Incepta, Energen, Punctua, Cognis and Teligen implantable cardioverter defibrillators (ICDs) and cardiac resynchronization therapy defibrillators (CRT-Ds), to reflect increased longevity projections for these devices. The longevity projections are based on data submitted to the FDA and vary for each device dependent on the model type and settings.

June 8, 2012 — Austin Heart announced its participation in CONNECT II, a global clinical trial that gives physicians access to a new imaging technology tool to fight peripheral arterial disease (PAD). The technology, called Ocelot, helps to eliminate the need for bypass surgeries and/or amputations in patients with the disease.

June 8, 2012 — Medtronic Inc. announced the U.S. launch of the Endurant II AAA Stent Graft System, which recently received approval from the U.S. Food and Drug Administration (FDA) for the minimally invasive treatment of abdominal aortic aneurysms through endovascular repair (EVAR), an alternative to major surgery.

June 8, 2012 — LifeWatch AG, a wireless cardiac monitoring service and home sleep test provider in the United States, announced the launch of the world’s first-of-its-kind healthcare solution smartphone, allowing consumers self-operation of a wide range of highly valuable embedded medical sensors as well as wellness-related applications and cloud-based services. With this new technology LifeWatch will be able to expand outside its core markets, targeting new customer segments, service offerings and geographies. A comprehensive presentation and live demonstration of the solution will be given in Zurich on June 27, 2012.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now